Genome Valley

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Genome Valley
Science Parks
Founded1999 Edit this on Wikidata
FounderKrishna Ella Edit this on Wikidata

Genome Valley is an Indian high-technology business district spread across 600 km² in Hyderabad, India.[1] It is located across the suburbs, Turkapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara, the Valley has developed as a cluster for Biomedical research, training and manufacturing.[2][3][4]


Genome valley was commissioned in 1999 as S. P. Biotech Park in a public-private partnership with Bharat Biotech International, and its founder Krishna Ella, alongside private infrastructure companies such as Shapoorji Pallonji Group and ICICI Bank.[5]

Alexandria Knowledge Park SEZ[edit]

In 2009, U.S.-based infrastructure giant Alexandria Real Estate Equities has announced its plans to invest in the bio-cluster, which led to the Alexandria Knowledge Park SEZ.[6] The biocluster at Shamirpet holds Certification mark by the United States Patent and Trademark Office and the European Union.[7]

IKP Knowledge Park[edit]

The IKP Knowledge Park is spread over 200 acres in Turakapally, is an initiative of ICICI Bank with five "innovation corridors" - a first of its kind knowledge-nurturing centre for Indian companies and a knowledge gateway for multinational companies".[8] The first phase of Innovation Corridor I, comprising 10 laboratories, around 3,000 ft² (300 m²) each, is operational and fully occupied. The second phase of Innovation Corridor I, comprising 16 laboratory modules of 1,700 ft² (170 m²) each, is ready for operation.

MN Park[edit]

In 2016, Mission Neutral Park has acquired specialized R&D assets in Genome Valley from US based Alexandria REIT and rechristened it as MN Park. It is a collaborative life sciences ecosystem in Genome Valley, Hyderabad consisting of Grade A R&D facilities.

It is spread over 400 acres including build-up facilities of around 600,000 sq.ft. provided to global tenants like Novartis, GlaxoSmithKline, Mylan and Ashland Inc. MN’s focus area: Preleased industrial assets and specialized office spaces to sectors including specialized warehousing, logistics, food processing, light manufacturing, pharmaceutical R&D, biotechnology etc.


R & D[edit]

Clockwise from upper left:

Contract Research Organizations and Healthcare[edit]

  • Ocimum Biosolutions
  • Excelra
  • Makro care
  • SIRO-Clinpharm
  • Sipra Labs
  • Alveus Pharmaceuticals
  • Sandor Proteomics
  • Laurus Labs
  • Bio-Axis
  • Clin Asia
  • Clintec International
  • Andronovo Labs
  • Piramal Clinical
  • Diacel
  • Vimta Labs
  • Aizant therapeutics
  • Incozen Therapeutics
  • Med-Himalayas
  • Sai advantum
  • Laxai Avanti
  • Mithros chemicals
  • Imptech Scientific


Further reading[edit]


  1. ^ Special Correspondent (22 November 2011). "Today's Paper / NATIONAL : BioAsia-2012 to focus on vaccines, IPR, CROs and investments". The Hindu. Retrieved 21 August 2012.
  2. ^ "BioSpectrumIndia - the business of biotech - Moving Towards Consolidation". Archived from the original on 5 November 2008. Retrieved 21 August 2012.
  3. ^ Our Bureau (12 February 2012). "Business Line : Industry & Economy / Economy : AP Govt making policies more industry-friendly, says CM". Retrieved 21 August 2012.
  4. ^ Our Bureau. "Business Line : Industry & Economy News : Tag from US lab may help drug-makers find markets". Retrieved 21 August 2012.
  5. ^ rediff. "Genome valley history". Retrieved 21 August 2012.
  6. ^ The Hindu. "Alexandria to invest 1000 cr in genome valley". Retrieved 21 August 2012.
  7. ^ Hyderabad's Genome Valley gets US certification, Indo Asian News Service Friday, 6 July 2007 |
  8. ^ "". Archived from the original on 24 September 2015. Retrieved 20 September 2015.
  9. ^ "US Pharmacopeia to set up lab in Hyderabad". Archived from the original on 18 June 2006. Retrieved 19 February 2006.
  10. ^ "'Lonza is investing Rs.405 cr in India'". Archived from the original on 2 October 2013. Retrieved 28 June 2013.
  11. ^ Udgirkar, Trushna. "Biocon to spend Rs 200 cr on R&D, manufacturing". Archived from the original on 22 March 2012. Retrieved 21 August 2012.
  12. ^ IANS (18 September 2014). "P&G, Cogent open Telangana plants, Johnson & Johnson begins work".
  13. ^ "Novartis India Limited, Amit Kumar, Dr Anuradha Sinha". 13 August 2009. Retrieved 21 August 2012.
  14. ^ Bayer Archived 2013-11-04 at the Wayback Machine
  15. ^ Our Bureau. "Bayer launches multi-crop breeding station in Hyderabad". The Hindu Business Line.
  16. ^ Our Bureau. "Business Line : Industry & Economy / Agri-biz : Monsanto opens Rs 28 cr seed conditioning facility at Shamirpet". Retrieved 21 August 2012.
  17. ^ "Merck completes talks with IKP on R&D unit". The Hindu. Chennai, India. 18 February 2007.
  18. ^ "Covidien's New R&D Centre in Hyderabad - Express Healthcare". Retrieved 21 August 2012.
  19. ^ BS Reporter (8 July 2010). "Celgene opens support centre in Hyd".
  20. ^ Our Bureau. "Rs 380-cr stem cell bank to come up in Hyerabad". The Hindu Business Line.